CD44 and neoplasm: The other method involved sorting the top 5% brightest staining cells with stem cell markers (ALDH and CD44) by FACS, on the basis of our recent findings that ALDH+CD44+ cells isolated from ascites-derived tumor cells show enhanced CSC properties (16).